Program Overview
This program provides a comprehensive introduction to the global pharmaceutical industry, exploring market size, regional distribution, product categories, business models, and evolving trends such as biosimilars and India’s growing leadership. Delivered by an industry expert , the course blends conceptual foundations with situational awareness, case studies from global pharma leaders, and interactive simulations. Participants will not only gain clarity on key industry jargon and frameworks but also learn how to apply these insights to resolve actual business challenges across pharma operations, strategy, and market expansion.
Features
- Interpret the global pharmaceutical market landscape, trends, and regional growth drivers.
- Differentiate between innovators, branded generics, generics, and biosimilars with practical business implications.
- Evaluate pharma business models (prescriptions, pharmacy chains, tenders) and their strategic impact.
- Assess India’s evolving role as the “Pharmacy of the World” and its future opportunities.
Target audiences
- Professionals in Pharma, Healthcare & Consulting
- Professionals in Strategy, Quality and R&D
- Professionals in Supply Chain & Operations
Curriculum
- 6 Sections
- 32 Lessons
- 1 Day
Expand all sectionsCollapse all sections
- The Global Pharmaceutical Market Landscape4
- Pharma Product Types & Business Size5
- Pharma Business Models6
- 3.1Prescription-driven business (physician influence)
- 3.2Retail / pharmacy chains (US & EU dominance)
- 3.3Tenders (government-driven procurement in Africa/Asia)
- 3.4Others – online pharmacies, telemedicine integrations
- 3.5Case Example: CVS, Apollo Pharmacy, NHS tendering models
- 3.6Exercise: Group simulation – “Winning a government tender vs. retail launch”
- The Rise of Biosimilars4
- Types of Pharma Manufacturers7
- 5.1Innovators (Pfizer, Roche, Novartis)
- 5.2Branded generics/generics (Sun Pharma, Dr. Reddy’s, Teva)
- 5.3Biopharma (Amgen, Biocon)
- 5.4Contract manufacturers (Lonza, WuXi)
- 5.5Specialty pharma (orphan drugs, rare diseases)
- 5.6Cosmetics, nutraceuticals, ayurvedic players
- 5.7Real-Life Example: Biocon’s global biosimilar partnerships
- India – The Pharmacy of the World6
- 6.1India’s contribution to global generics (20%+ by volume)
- 6.2Vaccine leadership (Serum Institute of India)
- 6.3Government initiatives & export dominance
- 6.4Future trajectory – biosimilars, biologics, digital pharma
- 6.5Case Example: India’s role in COVID-19 vaccines supply
- 6.6Interactive Activity: Scenario simulation – “Positioning India’s pharma industry in 2030”
Instructor
